HLA-DO (Galician Wikipedia)

Analysis of information sources in references of the Wikipedia article "HLA-DO" in Galician language version.

refsWebsite

Global rank Galician rank

13nih.gov

4^th place

6^th place

13doi.org

2^nd place

7^th place

1archive.org

6^th place

8^th place

1worldcat.org

5^th place

11^th place

1harvard.edu

18^th place

38^th place

archive.org

Owen JA, Punt J, Stranford SA, Jones PP, Kuby J (2013). Kuby immunology (7ª ed.). Nova York: W.H. Freeman. ISBN 978-1-4641-1991-0. OCLC 820117219.

doi.org

dx.doi.org

Pos W, Sethi DK, Wucherpfennig KW (outubro de 2013). "Mechanisms of peptide repertoire selection by HLA-DM". Trends in Immunology 34 (10): 495–501. PMC 3796002. PMID 23835076. doi:10.1016/j.it.2013.06.002.
Poluektov YO, Kim A, Hartman IZ, Sadegh-Nasseri S (2013-08-08). "HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation". PLOS ONE 8 (8): e71228. Bibcode:2013PLoSO...871228P. PMC 3738515. PMID 23951115. doi:10.1371/journal.pone.0071228.
Yin L, Stern LJ (outubro de 2013). "HLA-DM Focuses on Conformational Flexibility Around P1 Pocket to Catalyze Peptide Exchange". Frontiers in Immunology 4: 336. PMC 3797982. PMID 24146666. doi:10.3389/fimmu.2013.00336.
Chen X, Jensen PE (2014). "Biological function of HLA-DO (H2-O)". Critical Reviews in Immunology 34 (3): 215–25. PMID 24941074. doi:10.1615/critrevimmunol.2014009999.
Denzin LK (decembro de 2013). "Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance". Frontiers in Immunology 4: 465. PMC 3865790. PMID 24381574. doi:10.3389/fimmu.2013.00465.
Chen X, Jensen PE (xuño de 2004). "The expression of HLA-DO (H2-O) in B lymphocytes". Immunologic Research 29 (1–3): 19–28. PMID 15181267. doi:10.1385/IR:29:1-3:019.
Adler LN, Jiang W, Bhamidipati K, Millican M, Macaubas C, Hung SC, Mellins ED (marzo de 2017). "The Other Function: Class II-Restricted Antigen Presentation by B Cells". Frontiers in Immunology 8: 319. PMC 5362600. PMID 28386257. doi:10.3389/fimmu.2017.00319.
Mellins ED, Stern LJ (febreiro de 2014). "HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation". Current Opinion in Immunology 26: 115–22. PMC 3944065. PMID 24463216. doi:10.1016/j.coi.2013.11.005.
Adler LN, Jiang W, Bhamidipati K, Millican M, Macaubas C, Hung SC, Mellins ED (2017-03-23). "The Other Function: Class II-Restricted Antigen Presentation by B Cells". Frontiers in Immunology 8: 319. PMC 5362600. PMID 28386257. doi:10.3389/fimmu.2017.00319.
Welsh RA, Sadegh-Nasseri S (xuño de 2020). "The love and hate relationship of HLA-DM/DO in the selection of immunodominant epitopes". Current Opinion in Immunology 64: 117–123. PMC 7762731. PMID 32599219. doi:10.1016/j.coi.2020.05.007.
Liljedahl M, Kuwana T, Fung-Leung WP, Jackson MR, Peterson PA, Karlsson L (setembro de 1996). "HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport". The EMBO Journal 15 (18): 4817–24. PMC 452218. PMID 8890155. doi:10.1002/j.1460-2075.1996.tb00862.x.
Zwart W, Griekspoor A, Kuijl C, Marsman M, van Rheenen J, Janssen H, et al. (febreiro de 2005). "Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape". Immunity 22 (2): 221–33. PMID 15723810. doi:10.1016/S0960-9822(06)00414-3.
Nanaware PP, Jurewicz MM, Leszyk JD, Shaffer SA, Stern LJ (marzo de 2019). "HLA-DO Modulates the Diversity of the MHC-II Self-peptidome". Molecular & Cellular Proteomics 18 (3): 490–503. PMC 6398211. PMID 30573663. doi:10.1074/mcp.RA118.000956.

harvard.edu

adsabs.harvard.edu

Poluektov YO, Kim A, Hartman IZ, Sadegh-Nasseri S (2013-08-08). "HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation". PLOS ONE 8 (8): e71228. Bibcode:2013PLoSO...871228P. PMC 3738515. PMID 23951115. doi:10.1371/journal.pone.0071228.

nih.gov

ncbi.nlm.nih.gov

Pos W, Sethi DK, Wucherpfennig KW (outubro de 2013). "Mechanisms of peptide repertoire selection by HLA-DM". Trends in Immunology 34 (10): 495–501. PMC 3796002. PMID 23835076. doi:10.1016/j.it.2013.06.002.
Poluektov YO, Kim A, Hartman IZ, Sadegh-Nasseri S (2013-08-08). "HLA-DO as the optimizer of epitope selection for MHC class II antigen presentation". PLOS ONE 8 (8): e71228. Bibcode:2013PLoSO...871228P. PMC 3738515. PMID 23951115. doi:10.1371/journal.pone.0071228.
Yin L, Stern LJ (outubro de 2013). "HLA-DM Focuses on Conformational Flexibility Around P1 Pocket to Catalyze Peptide Exchange". Frontiers in Immunology 4: 336. PMC 3797982. PMID 24146666. doi:10.3389/fimmu.2013.00336.
Chen X, Jensen PE (2014). "Biological function of HLA-DO (H2-O)". Critical Reviews in Immunology 34 (3): 215–25. PMID 24941074. doi:10.1615/critrevimmunol.2014009999.
Denzin LK (decembro de 2013). "Inhibition of HLA-DM Mediated MHC Class II Peptide Loading by HLA-DO Promotes Self Tolerance". Frontiers in Immunology 4: 465. PMC 3865790. PMID 24381574. doi:10.3389/fimmu.2013.00465.
Chen X, Jensen PE (xuño de 2004). "The expression of HLA-DO (H2-O) in B lymphocytes". Immunologic Research 29 (1–3): 19–28. PMID 15181267. doi:10.1385/IR:29:1-3:019.
Adler LN, Jiang W, Bhamidipati K, Millican M, Macaubas C, Hung SC, Mellins ED (marzo de 2017). "The Other Function: Class II-Restricted Antigen Presentation by B Cells". Frontiers in Immunology 8: 319. PMC 5362600. PMID 28386257. doi:10.3389/fimmu.2017.00319.
Mellins ED, Stern LJ (febreiro de 2014). "HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation". Current Opinion in Immunology 26: 115–22. PMC 3944065. PMID 24463216. doi:10.1016/j.coi.2013.11.005.
Adler LN, Jiang W, Bhamidipati K, Millican M, Macaubas C, Hung SC, Mellins ED (2017-03-23). "The Other Function: Class II-Restricted Antigen Presentation by B Cells". Frontiers in Immunology 8: 319. PMC 5362600. PMID 28386257. doi:10.3389/fimmu.2017.00319.
Welsh RA, Sadegh-Nasseri S (xuño de 2020). "The love and hate relationship of HLA-DM/DO in the selection of immunodominant epitopes". Current Opinion in Immunology 64: 117–123. PMC 7762731. PMID 32599219. doi:10.1016/j.coi.2020.05.007.
Liljedahl M, Kuwana T, Fung-Leung WP, Jackson MR, Peterson PA, Karlsson L (setembro de 1996). "HLA-DO is a lysosomal resident which requires association with HLA-DM for efficient intracellular transport". The EMBO Journal 15 (18): 4817–24. PMC 452218. PMID 8890155. doi:10.1002/j.1460-2075.1996.tb00862.x.
Zwart W, Griekspoor A, Kuijl C, Marsman M, van Rheenen J, Janssen H, et al. (febreiro de 2005). "Spatial separation of HLA-DM/HLA-DR interactions within MIIC and phagosome-induced immune escape". Immunity 22 (2): 221–33. PMID 15723810. doi:10.1016/S0960-9822(06)00414-3.
Nanaware PP, Jurewicz MM, Leszyk JD, Shaffer SA, Stern LJ (marzo de 2019). "HLA-DO Modulates the Diversity of the MHC-II Self-peptidome". Molecular & Cellular Proteomics 18 (3): 490–503. PMC 6398211. PMID 30573663. doi:10.1074/mcp.RA118.000956.

worldcat.org

Owen JA, Punt J, Stranford SA, Jones PP, Kuby J (2013). Kuby immunology (7ª ed.). Nova York: W.H. Freeman. ISBN 978-1-4641-1991-0. OCLC 820117219.